Syngene, BIRAC set up centre for advanced protein studies in Bengaluru

Biocon arm Syngene International Friday said it has set up a centre for advanced protein studies in collaboration with Biotechnology Industry Research Assistance Council (BIRAC), at the former's campus in Bengaluru.

The centre will host a state-of-the-art good laboratory practices (GLP) accredited analytical laboratory, the company said in a filing to the BSE.

"India has immense scientific and entrepreneurial talent available in the country which gives it strong potential to emerge as the R&D hub for the global biotechnology industry," Syngene International MD Kiran Mazumdar Shaw said.

The centre for advanced protein studies (CAPS) facility will provide the right ecosystem for this talent to pursue their research objectives, she added.

The centre will run under the 'Innovate in India' programme of the National Biopharma Mission, it added.

The National Biopharma Mission is an industry-academia collaborative mission of the Department of Biotechnology and World Bank for accelerating early development of biopharmaceuticals and is being implemented by BIRAC, the filing said.

The centre will address the challenge of availability of GLP compliant analytical facility that the startups, small and medium sized enterprises (SMEs) and middle market enterprises (MMEs) and the academia in India have to face and will be a boost in advancing biopharma research and product development in the country, it added.

"It is indeed an honour for Syngene to collaborate with BIRAC in setting up the CAPS facility," Syngene International CEO Jonathan Hunt said.

Shares of Syngene International were trading at Rs 580 per scrip on the BSE, down 0.18 per cent from their previous close.